Skip to main content

Research at Alzheimer Society of Canada

1-855-705-4636
  • Find a Research Study
  • FAQs
  • Legal Disclaimer
  • Contact Us
  • Français

Alzheimer Society of Canada

Find a Research Study

Investigating tDCS for people with Alzheimer's Disease or Primary Progressive Aphasia

What is this Study about?

We are conducting three separate studies to explore the effects of transcranial Direct Current Stimulation (tDCS) in individuals with Alzheimer’s Disease or Primary Progressive Aphasia. tDCS is a non-invasive therapy that uses low electrical currents to stimulate specific areas of the brain. Previous research has suggested that tDCS can improve symptoms such as language difficulties and may help slow the progression of Alzheimer’s.

Our studies aim to investigate these effects in different contexts, including language therapy and overall mental abilities. Upon completion, participants will receive their study results to help guide their decisions about whether tDCS could be part of a long-term therapy plan.

What Will Happen in This Study?

Study 1: Language Improvement tDCS-Therapy for people with Alzheimer’s Disease

  • Description: Participants will complete three rounds of language therapy, each paired with brain stimulation. Each round consists of multiple stimulation sessions spread over three weeks. Two rounds will use active stimulation at different intensities, while one will use a placebo. This study aims to improve naming ability in people with Alzheimer’s disease.
  • Time Commitment: Over seven months, you'll take part in three rounds of stimulation sessions. Each round consists of nine stimulation sessions and three evaluations, spread over three weeks—meaning many days with no sessions at all. Most sessions last just 90 minutes, and never more than two hours. Plus, after each round, you’ll have a full two-month break to go about your normal routine.

Study 2: tDCS Language Enhancement for people with Primary Progressive Aphasia

  • Description: Participants will complete two rounds of brain stimulation aimed at boosting language abilities in individuals with Primary Progressive Aphasia. Each round consists of multiple stimulation sessions spread over three weeks. One round will use active stimulation, while the other will use a placebo.
  • Time Commitment: Over six months, you'll participate in just two rounds of stimulation sessions with a long three-month break in between. Each round lasts only three weeks, with 15 sessions scheduled Monday to Friday—giving you weekends off. Evaluations take place the week before and after, but most sessions are just 90 minutes, never more than two hours.

Study 3: Boosting Overall Mental Function with tDCS for people with Alzheimer's Disease

  • Description: Participants will complete three rounds of brain stimulation aimed at improving general cognition—everyday thinking skills like memory, attention, and problem-solving. Each round consists of multiple stimulation sessions spread over three weeks. Two rounds will use active stimulation at different intensities, while one will use a placebo.
  • Time Commitment: Over seven months, you'll take part in three rounds of stimulation sessions. Each round consists of nine stimulation sessions and three evaluations, spread over three weeks—meaning many days with no sessions at all. Most sessions last just 90 minutes, and never more than two hours. Plus, after each round, you’ll have a full two-month break to go about your normal routine.

Who is Eligible to Participate in this Study?

Person living with Alzheimer's disease

Get in Touch About this Study

Legal Disclaimer

Any materials or links provided herein are strictly for informational purposes only. The Alzheimer Society of Canada does not endorse nor recommend any of the manufacturers, products or institutions mentioned in any of these links or listings as suitable or appropriate for your particular situation or circumstances and disclaims any liability with respect to representations, warranties, including fitness for an intended particular use or purpose, and all other claims relating thereto, all of which remain strictly with the manufacturer or institution.

In no event shall the Alzheimer Society of Canada or any third parties mentioned on the website be liable for any damage (including, without limitation, incidental and consequential damages for personal injury/wrongful death, lost profits or damages resulting from lost data or business interruption) or personal injury (including death) resulting from the use, misuse or inability to use any activity, product or service mentioned herein, whether based in warranty, contract, tort or any other legal theory.

Everyone considering participating in any activity is encouraged to speak with their own doctor or health-care team before participating in any activity that may impact their health or well-being.

Clinical Trial

Target Population

Person living with Alzheimer’s disease

Target Age Group(s)

41-65, 66+

Study Location

In-Person

Baycrest (Toronto); CLSC Renee-Cassin (Montreal)

Ontario, Quebec

Study Contact

Alice Zhang
Baycrest

Recruitment Start Date

January 5, 2025

Recruitment End Date

September 1, 2028
  • Learn more about observational studies
  • Learn more about clinical trials
  • Brain donations
  • More useful links and resources

Alzheimer Society of Canada logo

Alzheimer Society of Canada
20 Eglinton Avenue West, 16th Floor
Toronto, Ontario M4R 1K8
Information and Referral Line: 1-855-705-4636
Email: research@alzheimer.ca

Charity registration number: 11878 4925 RR0001

Follow us:

  • Find us on Facebook
  • Follow us on Twitter
  • Follow us on Instagram
  • Subscribe to us on YouTube
  • Find us in LinkedIn

©2022 Alzheimer Society of Canada. All rights reserved.